TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 88 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $574,000 | +1.6% | 59,215 | +12.6% | 0.35% | -13.2% |
Q1 2021 | $565,000 | +13.0% | 52,580 | +54.8% | 0.40% | -15.4% |
Q4 2020 | $500,000 | +70.1% | 33,965 | +63.9% | 0.47% | +54.9% |
Q3 2020 | $294,000 | +39.3% | 20,720 | -20.6% | 0.31% | +43.0% |
Q2 2020 | $211,000 | – | 26,100 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 2,100,000 | $646,000 | 0.05% |
Matrix Capital Management Company, LP | 2,288,560 | $704,000 | 0.02% |
Tekla Capital Management LLC | 446,099 | $137,000 | 0.01% |
Realta Investment Advisors | 26,000 | $7,000 | 0.00% |
Virtu Financial LLC | 34,991 | $11,000 | 0.00% |
Baker Brothers Advisors | 505,262 | $155,000 | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 20,044 | $6,000 | 0.00% |
MORGAN STANLEY | 1,160,098 | $356,000 | 0.00% |
BANK OF MONTREAL /CAN/ | 18,333 | $6,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 102,725 | $31,000 | 0.00% |